Recent Quotes
View Full List
My Watchlist
01 Quantum Inc
APi Group Corporation Common Stock
Amplify CWP Growth & Income ETF
Aurora Spine Corp
Bioadaptives Inc
Bionoid Pharma Inc
CSI Compressco LP - common units
Coloplast As ADR
Defiance Leveraged Long + Income MSTR ETF
Everpure, Inc. Class A common stock
Exela Technologies, Inc. - 6.00% Series B Cumulative Convertible Perpetual
Fidelity Disruptive Finance ETF
First Trust Indxx Medical Devices ETF
Good Gaming Inc
Growlife Inc
Helix Energy Solutions Group, Inc. Common Stock
Impinj, Inc. - Common Stock
M.D. Sass Concentrated Value ETF
Mda Space Ltd
OFA Group - Class A Ordinary Shares
PDF Solutions, Inc. - Common Stock
Perma-Fix Environmental Services, Inc. - Common Stock
Qualigen Therapeutics, Inc. - Common Stock
SOPHiA GENETICS SA - Ordinary Shares
Sanderson Farms, Inc. - Common Stock
Select Medical Holdings Corporation Common Stock
Spectaire Holdings, Inc. - Common Stock
State Street SPDR Portfolio S&P 600 Small Cap ETF
Suncor Energy Inc. Common Stock
Super Micro Computer, Inc. - Depositary Shares
TELUS Corporation
TFS Financial Corporation - Common Stock
Timbercreek Financial Corp
Trulieve Cannabis Corp
Verona Pharma plc - American Depositary Shares
Vestas Wind Sys ADR
Victory Square Tech Ord
WideOpenWest, Inc. Common Stock
iShares Core 1-5 Year USD Bond ETF
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
(OP:
VNTXF
)
0.6000
UNCHANGED
Last Price
Updated: 9:53 AM EDT, Aug 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about VNTXF
Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
October 16, 2026
From
Vanta Holdings Inc.
Via
ACCESS Newswire
Vanta Attends 2026 All-In Summit in Los Angeles, a Leading Gathering of Business, Investment and Industry Leaders
September 17, 2026
From
Vanta Holdings Inc.
Via
ACCESS Newswire
Vanta Announces Engagement of Independent Trading Group for Market-Making Services to Support Strategic Capital Markets Initiatives
August 27, 2026
From
Vanta Holdings Inc.
Via
ACCESS Newswire
Vanta Announces Closing of First Tranche of Private Placement and Board of Directors Update
August 21, 2026
From
Vanta Holdings Inc.
Via
ACCESS Newswire
Vanta Commends U.S. FDA Advisory Committee Vote Recommending Inclusion of Six Peptide Substances on FDA's 503A Bulks List, Including BPC-157, TB-500 and MOTS-c
July 28, 2026
From
Vanta Holdings Inc.
Via
ACCESS Newswire
Vanta Announces Updated Time for Participation in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22, 2026, at 12:00 p.m. ET
July 21, 2026
From
Vanta Holdings Inc.
Via
ACCESS Newswire
Vanta to Participate in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22, 2026, at 10:00 a.m. ET
July 06, 2026
From
Vanta Holdings Inc.
Via
ACCESS Newswire
Vanta Announces Exclusive Global Brand Partnership and Worldwide Distribution Agreement for PickelBall Pixels (PBX) Branded Products Powered by Vanta Blackwater Featuring Patented Fulvic Isolation Technology(TM)
June 30, 2026
From
Vanta Holdings Inc.
Via
ACCESS Newswire
Vanta Announces Receipt of Distillery Manufacturer Licence, Expanding Manufacturing and Commercialization Capabilities at its British Columbia Beverage Manufacturing Facility
June 30, 2026
From
Vanta Holdings Inc.
Via
ACCESS Newswire
Vanta Announces Strategic Private Placement Financing to Advance U.S. Peptide Market Entry and Integrated Longevity and Consumer Health Sciences Platform
May 29, 2026
Via
ACCESS Newswire
Vanta Announces Strategic Agreement to Support U.S. Peptide Market Entry Through FDA-Registered Supply Chain and Compliant Payment Processing Infrastructure; Advancing U.S.-Focused Longevity and Consumer Health Sciences Platform
May 28, 2026
Via
ACCESS Newswire
Vanta Announces Closing of Second Tranche of Private Placement for Aggregate Gross Proceeds of $1 Million
May 06, 2026
Via
ACCESS Newswire
Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement
May 05, 2026
Via
ACCESS Newswire
Vanta Announces U.S. Ticker Symbol Change to VNTXF
March 26, 2026
Via
ACCESS Newswire
Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
March 25, 2026
Via
ACCESS Newswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.